Tango Therapeutics (TNGX) Q4 2024 Earnings

6NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.37
-0.32
-0.28
-0.24

Details

Expected EPS
-0.36671
Actual EPS
-0.27
Surprise EPS
0.1
Surprise Percent
+26.37%

Description

Tango Therapeutics (TNGX) has reported earnings of -0.27 per share for Q4 2024.

0 Comments

Share your thoughts